| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_20f72f5e4819753a3f7cf069136c36cf |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-0693
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-0464
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3344
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2005-14208
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3389 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M27-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-1723
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-16886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-16877
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-16827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-14232 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-168 |
| filingDate |
2021-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cde5b70ff74d7b852d5f8342c3a3fce0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb9346c6a5e45d13cb4f497baa9efa87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e77d17168b8eca2852bf6cf067f6486
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5e85c6a2e51df0c1206e638a7fff439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f20abed1a1d7e3d8f2e6fb7098607fd |
| publicationDate |
2022-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2022096745-A1 |
| titleOfInvention |
Subarachnoid fluid conduit system and kit |
| abstract |
A CSF management method for use with a patient forms a closed loop CSF circuit between two points on the patient's body. The CSF circuit has a therapeutic inlet to receive a therapeutic material (e.g. a drug), and a pump having a pump outlet to direct CSF along the CSF circuit. The method controls the pump to direct CSF from the pump outlet at a CSF rate that is different from the natural flow rate (i.e., the natural CSF flow rate). The therapeutic material is added to the CSF via the therapeutic input at a therapeutic rate. The CSF rate is different than the therapeutic rate and/or may be greater than the therapeutic rate. Alternative methods may control a bolus drug infusion to localize the application to a target region. |
| priorityDate |
2020-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |